Safe Therapeutic Economic Pharmaceutical Selection (STEPS): development, introduction and use in Northern Ireland

被引：10

作者：

Scott, Mike

Timoney, Mark

Mairs, Jill

Crealey, Grainne

Al Abaddi, Ibrahim

Brenninkmeijer, Rob

Janknegt, Robert

McElnay, James ^{[1
]}

机构：

[1] Queens Univ Belfast, Fac Med & Hlth Life Sci, Sch Pharm, Clin & Practice Res Grp, Belfast BT9 3BZ, Antrim, North Ireland

[2] Antrim Hosp, No Hlth & Social Care Trust, Belfast BT41 2RL, Antrim, North Ireland

[3] Dept Hlth Social Serv & Publ Safety, Belfast BT4 3SQ, Antrim, North Ireland

[4] Whiteabbey Hosp, No Hlth & Social Care Trust, Newtownabbey, North Ireland

[5] Royal Grp Hosp Trust, Educ Res Ctr, Clin Res Support Ctr, Belfast, Antrim, North Ireland

[6] Univ Jordan, Sch Pharm, Amman, Jordan

[7] Digitalis BV, Amsterdam, Netherlands

[8] Maasland Ziekenhuis, Dept Clin Pharm, Sittard, Netherlands

[9] Maasland Ziekenhuis, Dept Toxicol, Sittard, Netherlands

[10] Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland

来源：

EXPERT OPINION ON PHARMACOTHERAPY | 2007年 / 8卷

关键词：

economy; effectiveness; prescribing; quality safety;

D O I：

10.1517/14656566.8.S1.S57

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

A number of medicine selection methods have been used worldwide for formulary purposes. In Northern Ireland, integrated medicines management is being developed, and related projects have been carried out. This paper deals with the description of the STEPS (Safe Therapeutic Economic Pharmaceutical Selection) programme. The paper outlines the development of STEPS and its application as an element of a cost-effective medicines-management process in Northern Ireland.

引用

页码：S57 / S63

页数：7

共 17 条

[1] Impact of modified system of objectified judgement analysis (SOJA) methodology on prescribing costs of ACE inhibitors [J].

Alabbadi, Ibrahim ;

Crealey, Grainne ;

Scott, Michael ;

Baird, Simon ;

Trouton, Tom ;

Mairs, Jill ;

McElnay, James .

CLINICAL DRUG INVESTIGATION, 2006, 26 (09) :485-494

[2]

[Anonymous], 2001, SPOONF SUG MED MAN N

[3]

BRENNINKMEIJER RF, 1994, PHARM WEEKBLAD, V129, P185

[4] InforMatrix as an alternative tool in rational and transparent drug-decision making [J].

Brenninkmeijer, Rob ;

Mairs, Jill ;

Timoney, Mark ;

Scott, Mike ;

McElnay, James ;

Janknegt, Robert .

EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 :S31-S36

[5]

*DEPT HLTH, 2000, ORG MEM REP EXP GROU

[6] A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals [J].

Dooley, MJ ;

Allen, KM ;

Doecke, CJ ;

Galbraith, KJ ;

Taylor, GR ;

Bright, J ;

Carey, DL .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (04) :513-521

[7] Research into the use of health economics in decision making in the United Kingdom - Phase II - Is health economics 'for good or evil?' [J].

Duthie, T ;

Trueman, P ;

Chancellor, J ;

Diez, L .

HEALTH POLICY, 1999, 46 (02) :143-157

[8] The system of objectified judgement analysis (SOJA) - A tool in rational drug selection for formulary inclusion [J].

Janknegt, R ;

Steenhoek, A .

DRUGS, 1997, 53 (04) :550-562

[9] System of Objectified Judgement Analysis (SOJA) as a tool in rational and transparent drug-decision making [J].

Janknegt, Robert ;

Scott, Mike ;

Mairs, Jill ;

Timoney, Mark ;

McElnay, James ;

Brenninkmeijer, Rob .

EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 :S5-S14

[10]

KARR A, 2000, PHARM J, V265, P619

← 1 2 →